Chang WH, Vaughan AJ, Stamey AG, et al. Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer. bioRxiv : the preprint server for biology. 2026. doi:10.64898/2026.04.18.719329
PMCID
PMC13131474